Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia

Leukemia

Volumn 28, Issue 8, 2014, Pages 1617-1626

  Celton, M ^a,b,c   Forest, A ^a,b   Gosse, G ^a,b   Lemieux, S ^a,d   Hebert, J ^a,e   Sauvageau, G ^a,e,f   Wilhelm, B T ^a,b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b Laboratory for high throughput genomics   (Canada)

^c SPO   (France)

^d Centre for Structural and Functional Genomics   (Canada)

^e MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^f Laboratory of Molecular Genetics of Stem Cells   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELES; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; GATA2 TRANSCRIPTION FACTOR; HUMANS; KARYOTYPE; LEUKEMIA, MYELOID, ACUTE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84905690478     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.67     Document Type: Article

References (43)

1. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058-1066.
2. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363: 2424-2433.
3. Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998; 19: 219-220.
4. Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 2011; 44: 23-31.
5. Munker R, Nordberg ML, Veillon D, Williams BJ, Roggero A, Kern W et al. Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH). Leukemia Res 2009; 33: 1405-1408.
6. Greif PA, Dufour A, Konstandin NP, Ksienzyk B, Zellmeier E, Tizazu B et al. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood 2012; 120: 395-403.
7. Tsai F-Y, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994; 371: 221.
8. Tsai F-Y, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 1997; 89: 3636-3643.
9. Hahn CN, Chong C-E, Carmichael CL, Wilkins EJ, Brautigan PJ, Li X-C et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 2011; 43: 1012-1017.
10. Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, Li E et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 2004; 429: 900-903.
11. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW. Allelic variation in human gene expression. Science 2002; 297: 1143-1143.
12. Heap GA, Yang JH, Downes K, Healy BC, Hunt KA, Bockett N et al. Genome-wide analysis of allelic expression imbalance in human primary cells by highthroughput transcriptome resequencing. Hum Mol Genet 2010; 19: 122-134.
13. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001; 11: 863-874.
14. Sunyaev S, Ramensky V, Bork P. Towards a structural basis of human nonsynonymous single nucleotide polymorphisms. Trends Genet 2000; 16: 198-200.
15. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al. The sequence alignment/map format and SAMtools. Bioinformatics 2009; 25: 2078-2079.
16. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G et al. Integrative genomics viewer. Nat Biotechnol 2011; 29: 24-26.
17. Bastian M, Heymann S, Jacomy M. Gephi: An Open Source Software for Exploring and Manipulating Networks. International AAAI Conference on Weblogs and Social Media. AAAI Press: Menlo Park, CA, USA, 2009.
18. Blondel VD, Guillaume J-L, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. J Stat Mech 2008; 2008: P10008.
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
20. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010; 26: 2069-2070.
21. Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, Syrrou M et al. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leukemia Res 2010; 34: 148-153.
22. Chen T, Ueda Y, Xie S, Li EA. Novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with activede novo methylation. J Biol Chem 2002; 277: 38746-38754.
23. King-Underwood L, Pritchard-Jones K. Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood 1998; 91: 2961-2968.
24. Tong Q, Tsai J, Tan G, Dalgin Gk, Hotamisligil GkS. Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol Cell Biol 2005; 25: 706-715.
25. Furuhata A, Murakami M, Ito H, Gao S, Yoshida K, Sobue S et al. GATA-1 and GATA-2 binding to 3' enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines. Leukemia 2009; 23: 1270-1277.
26. Tong Q, Dalgin Gk Xu H, Ting C-N, Leiden JM, Hotamisligil GkS. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 2000; 290: 134-138.
27. Zhang Y, Chellappan SP. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 1995; 10: 2085.
28. Scott L, Civin C, Rorth P, Friedman A. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 1992; 80: 1725-1735.
29. Verstovsek S, Estey E, Manshouri T, Keating M, Kantarjian H, Giles FJ et al. High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome. Leuk Lymphoma 2001; 42: 511-516.
30. Hope KJ, Cellot S, Ting SB, MacRae T, Mayotte N, Iscove NN et al. An RNAi screen identifies Msi2 and Prox1 as having opposite roles in the regulation of hematopoietic stem cell activity. Cell Stem Cell 2010; 7: 101-113.
31. Lowry JA, Atchley WR. Molecular evolution of the GATA family of transcription factors: conservation within the DNA-binding domain. J Mol Evol 2000; 50: 103-115.
32. Verhaak RGW, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 2005; 106: 3747-3754.
33. Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996; 10: 1911.
34. Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009; 114: 144-147.
35. Dang L, Jin S, Su SM. IDH mutations in glioma and acute myeloid leukemia. Trends Mol Med 2010; 16: 387-397.
36. Gimelbrant A, Hutchinson JN, Thompson BR, Chess A. Widespread monoallelic expression on human autosomes. Science 2007; 318: 1136-1140.
37. Bonadies N, Foster SD, Chan W-I, Kvinlaug BT, Spensberger D, Dawson MA et al. Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemia. PloS One 2011; 6: e16330.
38. Hsu AP, Johnson KD, Falcone EL, Sanalkumar R, Sanchez L, Hickstein DD et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood 2013; 121: 3830-3837.
39. Gregg C, Zhang J, Weissbourd B, Luo S, Schroth GP, Haig D et al. High-resolution analysis of parent-of-origin allelic expression in the mouse brain. Science 2010; 329: 643-648.
40. DeVeale B, van der Kooy D, Babak T. Critical evaluation of imprinted gene expression by RNA-Seq: a new perspective. PLoS Genet 2012; 8: e1002600.
41. Fasan A, Eder C, Haferlach C, Grossmann V, Kohlmann A, Dicker F et al. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia 2012; 27: 482-485.
42. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012; 481: 506-510.
43. Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012; 366: 1090-1098.